Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses

Biophysical Journal

Volumn 96, Issue 7, 2009, Pages 2624-2636

  Nowak, Sarah A ^a   Chou, Tom ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MEMBRANE RECEPTOR; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS RECEPTOR;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DENSITY; ENDOCYTOSIS; EXPERIMENTAL STUDY; NONHUMAN; PARAMETER; PROBABILITY; PROTEIN BINDING; RIGIDITY; STOCHASTIC MODEL; VIRUS; VIRUS ENTRY; VIRUS SPIKE; BIOLOGICAL MODEL; KINETICS; METABOLISM; STATISTICS; TIME;

HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1;

ENDOCYTOSIS; KINETICS; MODELS, BIOLOGICAL; PROBABILITY; RECEPTORS, VIRUS; STOCHASTIC PROCESSES; TIME FACTORS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION; VIRUSES;

EID: 67649364152     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.01.018     Document Type: Article

References (64)

1. Dimitrov, D. S. 2004. Virus entry: molecular mechanisms and biomedical applications. Natl. Rev. 2:109-122.
2. Marsh, M., and A. Helenius. 2006. HIV entry inhibitors. Cell. 124: 729-740.
3. Duzgunes, N., M. C. Pedroso de Lima, L. Stamatatos, D. Flasher, D. Alford, et al. 1992. Fusion activity and inactivation of influenza virus: kinetics of low pH-induced fusion with cultured cells. J. Gen. Virol. 73:27-37.
4. Diaz-Griffero, F., S. A. Hoschander, and J. Brojatsch. 2002. Endocytosis is a critical step in entry of subgroup B avian leukosis viruses. J. Virol. 76:12866-12876.
5. Marsh, M., and R. Bron. 1997. SFV infection in CHO cells: cell-type specific restrictions to productive virus entry at the cell surface. J. Cell Sci. 110:95-103.
6. Reske, A., G. Pollara, C. Krummenacher, B. M. Chain, and D. R. Katz. 2007. Understanding HSV-1 entry glycoproteins. Rev. Med. Virol. 17:205-215.
7. Haan, K. M., W. W. Kwok, R. Longnecker, and P. Speck. 2000. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J. Virol. 74:2451-2454.
8. Hutt-Fletcher, L. M. 2007. Epstein-Barr virus entry. J. Virol. 81: 7825-7832.
9. Daecke, J., O. T. Fackler, M. T. Dittmar, and H. -G. Krusslich. 2005. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J. Virol. 79:1581-1594.
10. Schaeffer, E., V. B. Soros, and W. C. Greene. 2004. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J. Virol. 78:1375-1383.
11. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, et al. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:184-187.
12. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, et al. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:179-183.
13. Hill, C. M., H. Deng, D. Unutmaz, V. N. Kewalramani, L. Bastani, et al. 1997. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:6296-6304.
14. Chou, T. 2007. Stochastic entry of enveloped viruses: fusion versus. endocytosis. Biophys. J. 93:1116-1123.
15. Chang, M. I., P. Panorchan, T. M. Dobrowsky, Y. Tseng, and D. Wirtz. 2005. Single-molecule analysis of human immunodeficiency virus type 1 gp120-receptor interactions in living cells. J. Virol. 79:14748-14755.
16. Platt, E. J., J. P. Durnin, and D. Kabat. 2005. Kinetic factors control effi-ciencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. J. Virol. 79:4347-4356.
17. Lineberger, J. E., R. Danielsen, D. J. Hazuda, A. J. Simon, and M. D. Miller. 2002. Altering expression levels of human immunodefi-ciency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion. J. Virol. 76:3522-3533.
18. Yang, X., S. Kurteva, X. Ren, S. Lee, and J. Sodroski. 2006. Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells. J. Virol. 80:4388-4395.
19. Li, Q.-J., A. R. Dinner, S. Qi, D. J. Irvine, J. B. Huppa, et al. 2004. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat. Immunol. 5:791-799.
20. Yang, X., S. Kurteva, X. Ren, S. Lee, and J. Sodroski. 2005. Stoichiometry of envelope glycoprotein trimers in the entry of human immunode-ficiency virus type 1. J. Virol. 79:12132-12147.
21. Fok, P.-W., and T. Chou. 2007. Interface growth driven by surface kinetics and convection. SIAM J. Appl. Math. In press.
22. Gao, H., W. Shi, and L. B. Freund. 2005. Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA. 102:9469-9474.
23. Lerner, D. M., J. M. Deutsch, and G. F. Oster. 1993. How does a virus bud? Biophys. J. 65:73-79.
24. Deserno, M. 2004. Elastic deformation of a fluid membrane upon colloid binding. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 69:031903.
25. D'Orsogna, M. R., and T. Chou. 2005. Queuing and cooperativity in ligand-receptor binding. Phys. Rev. Lett. 95:170603.
26. Sun, S. X., and D. Wirtz. 2006. Mechanics of enveloped virus entry into host cells. Biophys. J. 90:L10.
27. Haque, M. E., and B. R. Lentz. 2002. Influence of gp41 fusion peptide on the kinetics of the poly(ethylene glycol)-mediated model membrane fusion. Biochemistry. 41:10866-10876.
28. Siegel, D. P. 1993. Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 65:2124-2223.
29. Markin, V. S., and J. P. Albanesi. 2002. Membrane fusion: stalk model revisited. Biophys. J. 82:693-712.
30. Monck, J. R., and J. M. Fernandez. 1996. The fusion pore and mechanisms of biological membrane fusion. Curr. Opin. Cell Biol. 8:524-533.
31. Müller, M., K. Katsov, and M. Schick. 2003. A new mechanism of model membrane fusion determined from Monte Carlo simulation. Biophys. J. 85:1611-1623.
32. Jahn, R., and H. Grubmüller. 2002. Membrane fusion. Curr. Opin. Cell Biol. 14:488-495.
33. Roux, A., K. Uyhazi, A. Frost, and P. D. Camilli. 2006. GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission. Nature. 441:528-531.
34. Royle, S. J., and L. Lagnado. 2003. Endocytosis at the synaptic terminal. J. Physiol. 553:345-355.
35. Kuhmann, S. E., E. J. Platt, S. L. Kozak, and D. Kabat. 2000. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 74:7005-7015.
36. Moore, J. P., and R. W. Doms. 2003. The entry of entry inhibitors: a fusion of science and medicine. Proc. Natl. Acad. Sci. USA. 100:10598-10602.
37. Reeves, J. D., S. A. Gallo, N. Ahmad, J. L. Miamidian, P. E. Harvey, et al. 2002. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/ coreceptor affinity, receptor density, and fusion kinetics. Proc. Natl. Acad. Sci. USA. 99:16249-16254.
38. Este, J. A., and A. Telenti. 2007. Virus entry: open sesame. Lancet. 370:81-88.
39. Reference deleted in proof.
40. Brandenburg, B., and X. Zhuang. 2007. Virus trafficking-learning from single virus tracking. Nat. Rev. Microbiol. 5:197-208.
41. Sieczarski, S. B., and G. R. Whittaker. 2002. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol. 76:10455-10464.
42. Seisenberger, G., M. U. Ried, T. Endre, H. Bning, M. Hallek, et al. 2001. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science. 294:1929-1932.
43. Platt, E. J., J. P. Durnin, U. Shinde, and D. Kabat. 2007. An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations. J. Mol. Biol. 374:64-79.
44. Grunewald, K., P. Desai, D. C. Winkler, J. B. Heymann, D. M. Belnap, et al. 2003. Three-dimensional structure of herpes simplex virus from cryo-electron tomography. Science. 302:1396-1398.
45. Bukrinskaya, A. G. 2004. HIV-1 assembly and maturation. Arch. Virol. 149:1067-1082.
46. Kol, N., Y. Shi, M. Tsvitov, D. Barlam, R. Z. Shneck, et al. 2007. A stiffness switch in human immunodeficiency virus. Biophys. J. 92:1777-1783.
47. Matarrese, P., and W. Malorni. 2005. Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death. Cell Death Differ. 12:932-941.
48. Qi, S. Y., J. T. Groves, and A. K. Chakraborty. 2001. Synaptic pattern formation during cellular recognition. Proc. Natl. Acad. Sci. USA. 98:6548-6553.
49. Sieczkarski, S. B., and G. R. Whittaker. 2002. Dissecting virus entry via endocytosis. J. Gen. Virol. 83:1535-1545.
50. Rust, M. J., M. Lakadamyali, F. Zhang, and X. Zhuang. 2004. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat. Struct. Mol. Biol. 11:567-573.
51. Shraimin, B. I. 1997. On the role of assembly kinetics in determining the structure of clathrin cages. Biophys. J. 72:953-957.
52. Mahy, B. W. J., and R. W. Compans, editors. (1996). Immunobiology and Pathogenesis of Persistent Virus Infections. Taylor & Francis, Abingdon, Oxfordshire, UK.
53. Wilson, W. R., and Sande M. A., editors. (2001). Current Diagnosis and Treatment in Infectious Diseases. McGraw-Hill Professional, Chicago, IL.
54. Clarke, R. W., N. Monnier, H. Li, D. Zhou, H. Browne, et al. 2007. Two-color fluorescence analysis of individual virions determines the distribution of the copy number of proteins in herpes simplex virus particles. Biophys. J. 93:1329-1337.
55. Zhu, P., J. Liu, J. Bess, E. Chertova, J. D. Lifson, et al. 2006. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature. 441:847-852.
56. Zhu, P., E. Chertova, J. Bess, J. D. Lifson, L. O. Arthur, et al. 2003. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA. 100:15812-15817.
57. Myszka, D. G., R. W. Sweet, P. Hensley, M. Brigham-Burke, P. D. Kwong, et al. 2000. Energetics of the HIV gp 120-CD4 binding reaction. Proc. Natl. Acad. Sci. USA. 97:9026-9031.
58. Choe, H., K. A. Martin, M. Farzan, J. Sodroski, N. P. Gerard, et al. 1998. Structural interactions between chemokine receptors, gp120 Env and CD4. Semin. Immunol. 10:249-257.
59. Liu, S., S. Fan, and Z. Sun. 2003. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling. J. Mol. Model. 9:329-336.
60. Finnegan, C. M., S. S. Rawat, E. H. Cho, D. L. Guiffre, S. Lockett, et al. 2007. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J. Virol. 81:5294-5304.
61. Shen, W. -C., and S. G. Louie. 1999. Immunology for Pharmacy Students CRC Press, Boca Raton, FL.
62. Shaw A. J., editor. (1996). Epithelial Cell Culture: A Practical Approach. Oxford University Press, Oxford, UK.
63. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
64. Baumann, H., and R. Keller. 1997. Which glycosaminoglycans are suitable for antithrombogenic or athrombogenic coatings of biomaterials? Part II: Covalently immobilized endothelial cell surface heparan sulfate (ESHS) and heparin (HE) on synthetic polymers and results of animal experiments. Semin. Thromb. Hemost. 23:215-223.